Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-23-016507)

Filing Details

Accession Number:: 0001209191-23-016507
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-03-06 18:55:56
Reporting Period:: 2023-03-06

Accepted Time:: 2023-03-06 18:55:56
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1662774	Quince Therapeutics Inc.	QNCX	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1606905	Ted Monohon	C/O Quince Therapeutics, Inc. 601 Gateway Blvd., Suite 1250 South San Francisco CA 94080	Chief Accounting Officer & Vp	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2023-03-06	1,871	$0.98	27,440	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

Represents shares sold to satisfy tax withholding obligations that arose in connection with the vesting of 4,250 shares of Restricted Stock Units granted on March 3, 2022. The sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 23, 2022.